These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32545182)
1. Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies. Dey S; Trau M; Koo KM Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32545182 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis of immunomarkers in vivo via multiplexed surface enhanced Raman spectroscopy with gold nanostars. Ou YC; Webb JA; O'Brien CM; Pence IJ; Lin EC; Paul EP; Cole D; Ou SH; Lapierre-Landry M; DeLapp RC; Lippmann ES; Mahadevan-Jansen A; Bardhan R Nanoscale; 2018 Jul; 10(27):13092-13105. PubMed ID: 29961778 [TBL] [Abstract][Full Text] [Related]
3. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy. Kim J; Hong J; Lee J; Fakhraei Lahiji S; Kim YH J Control Release; 2021 Apr; 332():109-126. PubMed ID: 33571549 [TBL] [Abstract][Full Text] [Related]
6. Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications. John C; Jain K; Masanam HB; Narasimhan AK; Natarajan A Micromachines (Basel); 2022 Dec; 13(12):. PubMed ID: 36557516 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress. Rastin F; Javid H; Oryani MA; Rezagholinejad N; Afshari AR; Karimi-Shahri M Int Immunopharmacol; 2024 Jan; 126():111055. PubMed ID: 37992445 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand? Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310 [TBL] [Abstract][Full Text] [Related]
17. Glucose detection through surface-enhanced Raman spectroscopy: A review. Sun X Anal Chim Acta; 2022 May; 1206():339226. PubMed ID: 35473867 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers. Inthagard J; Edwards J; Roseweir AK Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159 [TBL] [Abstract][Full Text] [Related]
19. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy. Yang J; Zhang C Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718 [TBL] [Abstract][Full Text] [Related]
20. The Role of Traditional Chinese Medicine in Cancer Immunotherapy: Current Status and Future Directions. Xie J; Huang H; Li X; Ouyang L; Wang L; Liu D; Wei X; Tan P; Tu P; Hu Z Am J Chin Med; 2023; 51(7):1627-1651. PubMed ID: 37638827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]